Pradaxa (dabigatran) is an oral factor Xa inhibitor that prevents clotting and has been approved as an effective alternative to the anti-coagulant warfarin (Coumadin). The marketed advantage for Pradaxa is that blood tests are not required to monitor dosage and its...